Literature DB >> 15650219

Inhibition of interferon signaling by the New York 99 strain and Kunjin subtype of West Nile virus involves blockage of STAT1 and STAT2 activation by nonstructural proteins.

Wen Jun Liu1, Xiang Ju Wang, Vladislav V Mokhonov, Pei-Yong Shi, Richard Randall, Alexander A Khromykh.   

Abstract

The interferon (IFN) response is the first line of defense against viral infections, and the majority of viruses have developed different strategies to counteract IFN responses in order to ensure their survival in an infected host. In this study, the abilities to inhibit IFN signaling of two closely related West Nile viruses, the New York 99 strain (NY99) and Kunjin virus (KUN), strain MRM61C, were analyzed using reporter plasmid assays, as well as immunofluorescence and Western blot analyses. We have demonstrated that infections with both NY99 and KUN, as well as transient or stable transfections with their replicon RNAs, inhibited the signaling of both alpha/beta IFN (IFN-alpha/beta) and gamma IFN (IFN-gamma) by blocking the phosphorylation of STAT1 and its translocation to the nucleus. In addition, the phosphorylation of STAT2 and its translocation to the nucleus were also blocked by KUN, NY99, and their replicons in response to treatment with IFN-alpha. IFN-alpha signaling and STAT2 translocation to the nucleus was inhibited when the KUN nonstructural proteins NS2A, NS2B, NS3, NS4A, and NS4B, but not NS1 and NS5, were expressed individually from the pcDNA3 vector. The results clearly demonstrate that both NY99 and KUN inhibit IFN signaling by preventing STAT1 and STAT2 phosphorylation and identify nonstructural proteins responsible for this inhibition.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15650219      PMCID: PMC544092          DOI: 10.1128/JVI.79.3.1934-1942.2005

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  31 in total

1.  Antibody responses in rabbits to the group B arbovirus Kumjin: serologic activity of the fractionated immunoglobulins in homologous and heterologous reactions.

Authors:  E G Westaway
Journal:  J Immunol       Date:  1968-03       Impact factor: 5.422

2.  The beta-interferon promoter responds to priming through multiple independent regulatory elements.

Authors:  P King; S Goodbourn
Journal:  J Biol Chem       Date:  1994-12-02       Impact factor: 5.157

3.  STAT1 is inactivated by a caspase.

Authors:  P King; S Goodbourn
Journal:  J Biol Chem       Date:  1998-04-10       Impact factor: 5.157

4.  Cytopathic and noncytopathic interferon responses in cells expressing hepatitis C virus subgenomic replicons.

Authors:  Ju-Tao Guo; Qing Zhu; Christoph Seeger
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

5.  Tetracycline-inducible packaging cell line for production of flavivirus replicon particles.

Authors:  Tracey J Harvey; Wen Jun Liu; Xiang Ju Wang; Richard Linedale; Michael Jacobs; Andrew Davidson; Thuy T T Le; Itaru Anraku; Andreas Suhrbier; Pei-Yong Shi; Alexander A Khromykh
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

6.  Nonstructural proteins NS1 and NS2 of bovine respiratory syncytial virus block activation of interferon regulatory factor 3.

Authors:  Birgit Bossert; Sabrina Marozin; Karl-Klaus Conzelmann
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

7.  The host response to West Nile Virus infection limits viral spread through the activation of the interferon regulatory factor 3 pathway.

Authors:  Brenda L Fredericksen; Maria Smith; Michael G Katze; Pei-Yong Shi; Michael Gale
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

8.  Blocking of the alpha interferon-induced Jak-Stat signaling pathway by Japanese encephalitis virus infection.

Authors:  Ren-Jye Lin; Ching-Len Liao; Elong Lin; Yi-Ling Lin
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

9.  Immunodominant epitopes on the NS1 protein of MVE and KUN viruses serve as targets for a blocking ELISA to detect virus-specific antibodies in sentinel animal serum.

Authors:  R A Hall; A K Broom; A C Hartnett; M J Howard; J S Mackenzie
Journal:  J Virol Methods       Date:  1995-02       Impact factor: 2.014

10.  Inhibition of interferon signaling by dengue virus.

Authors:  Jorge L Muñoz-Jordan; Gilma G Sánchez-Burgos; Maudry Laurent-Rolle; Adolfo García-Sastre
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-11       Impact factor: 11.205

View more
  150 in total

1.  A single amino acid in nonstructural protein NS4B confers virulence to dengue virus in AG129 mice through enhancement of viral RNA synthesis.

Authors:  Dixon Grant; Grace K Tan; Min Qing; Jowin K W Ng; Andy Yip; Gang Zou; Xuping Xie; Zhiming Yuan; Mark J Schreiber; Wouter Schul; Pei-Yong Shi; Sylvie Alonso
Journal:  J Virol       Date:  2011-06-01       Impact factor: 5.103

2.  Characterization of dengue virus resistance to brequinar in cell culture.

Authors:  Min Qing; Gang Zou; Qing-Yin Wang; Hao Ying Xu; Hongping Dong; Zhiming Yuan; Pei-Yong Shi
Journal:  Antimicrob Agents Chemother       Date:  2010-07-06       Impact factor: 5.191

3.  Type 1 IFN-independent activation of a subset of interferon stimulated genes in West Nile virus Eg101-infected mouse cells.

Authors:  Joanna A Pulit-Penaloza; Svetlana V Scherbik; Margo A Brinton
Journal:  Virology       Date:  2012-02-03       Impact factor: 3.616

4.  West Nile virus infection induces depletion of IFNAR1 protein levels.

Authors:  Jared D Evans; Rachel A Crown; Ji A Sohn; Christoph Seeger
Journal:  Viral Immunol       Date:  2011-08       Impact factor: 2.257

Review 5.  Cell-intrinsic innate immune control of West Nile virus infection.

Authors:  Michael S Diamond; Michael Gale
Journal:  Trends Immunol       Date:  2012-06-20       Impact factor: 16.687

6.  Differential effects of mutations in NS4B on West Nile virus replication and inhibition of interferon signaling.

Authors:  Jared D Evans; Christoph Seeger
Journal:  J Virol       Date:  2007-08-22       Impact factor: 5.103

7.  Identification of novel small-molecule inhibitors of West Nile virus infection.

Authors:  Amine O Noueiry; Paul D Olivo; Urszula Slomczynska; Yi Zhou; Ben Buscher; Brian Geiss; Michael Engle; Robert M Roth; Kyung Min Chung; Melanie Samuel; Michael S Diamond
Journal:  J Virol       Date:  2007-08-22       Impact factor: 5.103

Review 8.  West Nile virus infection and immunity.

Authors:  Mehul S Suthar; Michael S Diamond; Michael Gale
Journal:  Nat Rev Microbiol       Date:  2013-02       Impact factor: 60.633

9.  Interferon regulatory factor IRF-7 induces the antiviral alpha interferon response and protects against lethal West Nile virus infection.

Authors:  Stephane Daffis; Melanie A Samuel; Mehul S Suthar; Brian C Keller; Michael Gale; Michael S Diamond
Journal:  J Virol       Date:  2008-06-18       Impact factor: 5.103

10.  West Nile virus nonstructural protein 1 inhibits TLR3 signal transduction.

Authors:  Jason R Wilson; Paola Florez de Sessions; Megan A Leon; Frank Scholle
Journal:  J Virol       Date:  2008-06-18       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.